| Primary |
| Product Used For Unknown Indication |
25.6% |
| Pain |
11.6% |
| Hypertension |
9.3% |
| Constipation |
4.7% |
| Metastatic Malignant Melanoma |
4.7% |
| Neoplasm |
4.7% |
| Non-small Cell Lung Cancer Stage Iv |
4.7% |
| Pancreatic Carcinoma |
4.7% |
| Prophylaxis |
4.7% |
| Abdominal Pain |
2.3% |
| Anticoagulant Therapy |
2.3% |
| Depression |
2.3% |
| Duodenogastric Reflux |
2.3% |
| Dyslipidaemia |
2.3% |
| Femur Fracture |
2.3% |
| Hyperphosphataemia |
2.3% |
| Hypothyroidism |
2.3% |
| Ill-defined Disorder |
2.3% |
| Infection |
2.3% |
| Myocardial Ischaemia |
2.3% |
|
| Vomiting |
33.3% |
| Urinary Tract Infection |
22.2% |
| Congestive Cardiomyopathy |
11.1% |
| Hypothyroidism |
11.1% |
| Malaise |
11.1% |
| Renal Failure Chronic |
11.1% |
|
| Secondary |
| Prostate Cancer |
12.5% |
| Hypertension |
9.7% |
| Product Used For Unknown Indication |
8.7% |
| Colorectal Cancer |
7.6% |
| Prophylaxis |
7.4% |
| Nausea |
6.4% |
| Pain |
5.5% |
| Neoplasm Malignant |
4.8% |
| Premedication |
4.8% |
| Malignant Melanoma |
4.7% |
| Hepatitis C |
3.5% |
| Non-small Cell Lung Cancer Stage Iv |
3.5% |
| Insomnia |
3.4% |
| Rheumatoid Arthritis |
3.3% |
| Drug Use For Unknown Indication |
3.2% |
| Constipation |
3.1% |
| Ovarian Cancer |
2.5% |
| Type 2 Diabetes Mellitus |
1.9% |
| Abdominal Pain |
1.8% |
| Diabetes Mellitus |
1.8% |
|
| Vomiting |
7.0% |
| Wound Dehiscence |
7.0% |
| Neoplasm Malignant |
6.6% |
| Pleural Effusion |
5.8% |
| Renal Failure Acute |
5.8% |
| Respiratory Failure |
5.8% |
| Death |
5.4% |
| White Blood Cell Count Decreased |
5.4% |
| Neutropenia |
5.0% |
| Peripheral Motor Neuropathy |
5.0% |
| Thrombocytopenia |
5.0% |
| Urinary Tract Infection |
5.0% |
| Pyrexia |
4.5% |
| Hyponatraemia |
4.1% |
| Septic Shock |
4.1% |
| Anaemia |
3.7% |
| Dehydration |
3.7% |
| Febrile Neutropenia |
3.7% |
| Hypokalaemia |
3.7% |
| Nausea |
3.7% |
|
| Concomitant |
| Hypertension |
14.4% |
| Prophylaxis |
13.6% |
| Product Used For Unknown Indication |
13.1% |
| Diabetes Mellitus |
9.5% |
| Atrial Fibrillation |
8.7% |
| Drug Use For Unknown Indication |
6.6% |
| Thrombosis Prophylaxis |
6.1% |
| Hypercholesterolaemia |
5.0% |
| Type 2 Diabetes Mellitus |
3.7% |
| Pain |
2.9% |
| Angina Pectoris |
2.8% |
| Percutaneous Coronary Intervention |
2.5% |
| Multiple Myeloma |
1.8% |
| Myocardial Infarction |
1.7% |
| Acute Coronary Syndrome |
1.5% |
| Peripheral Arterial Occlusive Disease |
1.4% |
| Cerebrovascular Accident Prophylaxis |
1.2% |
| Gastritis Prophylaxis |
1.2% |
| Platelet Aggregation Inhibition |
1.2% |
| Prostate Cancer |
1.2% |
|
| Disability |
20.5% |
| Death |
12.9% |
| Urosepsis |
12.1% |
| Renal Failure Acute |
5.3% |
| Febrile Neutropenia |
4.5% |
| Liver Function Test Abnormal |
4.5% |
| Off Label Use |
4.5% |
| Respiratory Failure |
3.8% |
| Pyrexia |
3.0% |
| Rash Pruritic |
3.0% |
| Respiratory Distress |
3.0% |
| Syncope |
3.0% |
| Thrombocytopenia |
3.0% |
| Vomiting |
3.0% |
| Gastric Polyps |
2.3% |
| Hypoglycaemia |
2.3% |
| Hypotension |
2.3% |
| In-stent Coronary Artery Restenosis |
2.3% |
| Medication Error |
2.3% |
| Stomatitis |
2.3% |
|
| Interacting |
|
| Drug Interaction |
50.0% |
| Hypercalcaemia |
50.0% |
|
